Handok (002390) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Handok (002390) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩154.83 Million ≈ $104.93K USD) by net assets (₩267.90 Billion ≈ $181.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Handok stock valuation for the company's overall valuation and market capitalisation.
Handok - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Handok's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Handok Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Handok ranked by their cash flow conversion efficiency. Explore earnings quality score of Handok to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kapsch Traffic
VI:KTCG
|
0.636x |
|
EN Shoham Business Ltd
TA:SHOM
|
-0.068x |
|
Hotron Precision Electronic Industrial Co Ltd
TW:3092
|
-0.046x |
|
Tan Chong Motor Holdings Bhd
KLSE:4405
|
0.024x |
|
Kpx Green Chem
KO:083420
|
0.108x |
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
-0.018x |
|
SSF Home Group Berhad
KLSE:0287
|
0.146x |
|
kenturn Nano Tec Co Ltd
TWO:4561
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Handok (2011–2025)
The table below shows the annual cash flow conversion efficiency of Handok from 2011 to 2025. View 002390 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩278.32 Billion ≈ $188.61 Million |
₩3.98 Billion ≈ $2.70 Million |
0.014x | +248.38% |
| 2024-12-31 | ₩289.06 Billion ≈ $195.89 Million |
₩-2.79 Billion ≈ $-1.89 Million |
-0.010x | -109.13% |
| 2023-12-31 | ₩340.63 Billion ≈ $230.84 Million |
₩35.98 Billion ≈ $24.38 Million |
0.106x | +32.15% |
| 2022-12-31 | ₩381.86 Billion ≈ $258.78 Million |
₩30.52 Billion ≈ $20.68 Million |
0.080x | -17.56% |
| 2021-12-31 | ₩384.00 Billion ≈ $260.23 Million |
₩37.23 Billion ≈ $25.23 Million |
0.097x | +52.09% |
| 2020-12-31 | ₩381.85 Billion ≈ $258.77 Million |
₩24.34 Billion ≈ $16.50 Million |
0.064x | +149.23% |
| 2019-12-31 | ₩343.99 Billion ≈ $233.12 Million |
₩8.80 Billion ≈ $5.96 Million |
0.026x | -72.79% |
| 2018-12-31 | ₩313.38 Billion ≈ $212.37 Million |
₩29.46 Billion ≈ $19.96 Million |
0.094x | +302.39% |
| 2017-12-31 | ₩290.71 Billion ≈ $197.01 Million |
₩6.79 Billion ≈ $4.60 Million |
0.023x | +179.47% |
| 2016-12-31 | ₩289.25 Billion ≈ $196.02 Million |
₩-8.50 Billion ≈ $-5.76 Million |
-0.029x | -160.97% |
| 2015-12-31 | ₩303.71 Billion ≈ $205.82 Million |
₩14.64 Billion ≈ $9.92 Million |
0.048x | -59.42% |
| 2014-12-31 | ₩307.77 Billion ≈ $208.57 Million |
₩36.56 Billion ≈ $24.78 Million |
0.119x | +276.75% |
| 2013-12-31 | ₩294.28 Billion ≈ $199.43 Million |
₩9.28 Billion ≈ $6.29 Million |
0.032x | -26.21% |
| 2012-12-31 | ₩287.25 Billion ≈ $194.67 Million |
₩12.28 Billion ≈ $8.32 Million |
0.043x | -75.26% |
| 2011-12-31 | ₩278.34 Billion ≈ $188.62 Million |
₩48.08 Billion ≈ $32.59 Million |
0.173x | -- |
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more